These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7146043)

  • 21. Discriminative stimulus properties of quipazine: direct serotonergic mediation.
    White FJ; Appel JB; Kuhn DM
    Neuropharmacology; 1979 Feb; 18(2):143-51. PubMed ID: 34803
    [No Abstract]   [Full Text] [Related]  

  • 22. Lysergic acid diethylamide: evidence for stimulation of pituitary dopamine receptors.
    Meltzer HY; Fessler RG; Simonovic M; Doherty J; Fang VS
    Psychopharmacology (Berl); 1977 Aug; 54(1):39-44. PubMed ID: 143671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Behavioral effects of quipazine in the cat.
    Trulson ME; Brandstetter JW; Crisp T; Jacobs BL
    Eur J Pharmacol; 1982 Mar; 78(3):295-305. PubMed ID: 6461558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discriminative stimulus effects of a low dose of apomorphine in the rat.
    Tang AH; Franklin SR
    Psychopharmacology (Berl); 1987; 91(1):61-6. PubMed ID: 3103160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discriminative stimulus properties of lergotrile.
    Cunningham KA; Callahan PM; Appel JB
    J Pharmacol Exp Ther; 1984 Jul; 230(1):47-52. PubMed ID: 6146709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonergic modulation of footshock induced aggression in paired rats.
    Datla KP; Mitra SK; Bhattacharya SK
    Indian J Exp Biol; 1991 Jul; 29(7):631-5. PubMed ID: 1839019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sites.
    Friedman RL; Barrett RJ; Sanders-Bush E
    J Pharmacol Exp Ther; 1984 Mar; 228(3):628-35. PubMed ID: 6707913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clozapine blocks disruptive and discriminative stimulus effects of quipazine.
    Friedman RL; Sanders-Bush E; Barrett RL
    Eur J Pharmacol; 1984 Oct; 106(1):191-3. PubMed ID: 6529966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of effect of choline and narcotic antagonists upon apomorphine discrimination.
    Schechter MD
    Eur J Pharmacol; 1980 Nov; 68(2):187-91. PubMed ID: 7202485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tonic immobility in domestic fowl: anticataleptic effects of quipazine.
    Wallnau LB
    Pharmacol Biochem Behav; 1980 Mar; 12(3):347-52. PubMed ID: 7190287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of quipazine on blood pressure in pithed rats.
    Shin YK; Svinareff P; Schmitt-Jubeau H; Schmitt H
    Arch Int Pharmacodyn Ther; 1983 Jul; 264(1):73-81. PubMed ID: 6138006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different dopaminergic mechanisms for amfonelic acid, amphetamine and apomorphine.
    Schechter MD
    Pharmacol Biochem Behav; 1980 Oct; 13(4):497-500. PubMed ID: 7433481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for a direct dopaminergic effect of lisuride.
    Schechter MD
    Pharmacol Biochem Behav; 1984 Aug; 21(2):185-9. PubMed ID: 6483929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the serotonin agonist, quipazine, on luteinizing hormone and prolactin release: evidence for serotonin-catecholamine interactions.
    Lynch CO; Johnson MD; Crowley WR
    Life Sci; 1984 Oct; 35(14):1481-7. PubMed ID: 6148678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mescaline elicits behavioral effects in cats by an action at both serotonin and dopamine receptors.
    Trulson ME; Crisp T; Henderson LJ
    Eur J Pharmacol; 1983 Dec; 96(1-2):151-4. PubMed ID: 6581976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of opiates on the discriminative stimulus properties of dopamine agonists.
    Hernandez LL; Holohean AM; Appel JB
    Pharmacol Biochem Behav; 1978 Oct; 9(4):459-63. PubMed ID: 733832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of quipazine and fluoxetine on extinction of a previously-reinforced operant response in rats.
    Beninger RJ
    Pharmacol Biochem Behav; 1984 Oct; 21(4):533-7. PubMed ID: 6334317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opiate-serotonin synergism stimulating luteinizing hormone release in estrogen-progesterone-primed ovariectomized rats: mediation by serotonin2 receptors.
    Lenahan SE; Seibel HR; Johnson JH
    Endocrinology; 1987 Apr; 120(4):1498-502. PubMed ID: 3830057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of anorexia and motor disruption by cyclazocine and quipazine.
    Henck JW; Rezabek DH; Rech RH
    Pharmacol Biochem Behav; 1985 May; 22(5):671-6. PubMed ID: 4011631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine D2 receptors play a role in the (-)-apomorphine-like discriminative stimulus effects of (+)-PD 128907.
    Kleven MS; Koek W
    Eur J Pharmacol; 1997 Feb; 321(1):1-4. PubMed ID: 9083778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.